BRAIDO, FULVIO
 Distribuzione geografica
Continente #
EU - Europa 22.762
AS - Asia 2.623
NA - Nord America 1.851
SA - Sud America 201
AF - Africa 53
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 1
Totale 27.496
Nazione #
IT - Italia 22.241
US - Stati Uniti d'America 1.721
SG - Singapore 1.091
CN - Cina 625
VN - Vietnam 388
BD - Bangladesh 221
FR - Francia 198
BR - Brasile 121
HK - Hong Kong 107
FI - Finlandia 80
DE - Germania 68
NL - Olanda 58
CA - Canada 45
AR - Argentina 35
JP - Giappone 33
MX - Messico 30
IQ - Iraq 26
ES - Italia 24
ID - Indonesia 22
IN - India 22
CH - Svizzera 17
GB - Regno Unito 17
CO - Colombia 11
PH - Filippine 11
IE - Irlanda 10
GT - Guatemala 9
KE - Kenya 9
MA - Marocco 9
EC - Ecuador 8
NP - Nepal 8
SA - Arabia Saudita 8
TT - Trinidad e Tobago 8
PY - Paraguay 7
RU - Federazione Russa 7
ZA - Sudafrica 7
AT - Austria 6
HN - Honduras 6
TR - Turchia 6
UZ - Uzbekistan 6
AU - Australia 5
CL - Cile 5
PK - Pakistan 5
PL - Polonia 5
TH - Thailandia 5
VE - Venezuela 5
AE - Emirati Arabi Uniti 4
CR - Costa Rica 4
DO - Repubblica Dominicana 4
JM - Giamaica 4
MY - Malesia 4
SE - Svezia 4
UA - Ucraina 4
AZ - Azerbaigian 3
BO - Bolivia 3
BS - Bahamas 3
DZ - Algeria 3
EG - Egitto 3
HR - Croazia 3
JO - Giordania 3
KG - Kirghizistan 3
KR - Corea 3
KZ - Kazakistan 3
LB - Libano 3
NI - Nicaragua 3
OM - Oman 3
PE - Perù 3
PR - Porto Rico 3
PT - Portogallo 3
SN - Senegal 3
SV - El Salvador 3
TW - Taiwan 3
UY - Uruguay 3
BE - Belgio 2
BJ - Benin 2
CD - Congo 2
IL - Israele 2
KN - Saint Kitts e Nevis 2
MD - Moldavia 2
MU - Mauritius 2
NG - Nigeria 2
PA - Panama 2
SI - Slovenia 2
TN - Tunisia 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BF - Burkina Faso 1
BG - Bulgaria 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CZ - Repubblica Ceca 1
ET - Etiopia 1
GA - Gabon 1
GD - Grenada 1
HU - Ungheria 1
IR - Iran 1
KH - Cambogia 1
KW - Kuwait 1
KY - Cayman, isole 1
LC - Santa Lucia 1
Totale 27.483
Città #
Genova 13.147
Genoa 5.474
Rapallo 1.871
Vado Ligure 1.422
Singapore 533
San Jose 428
Ashburn 212
Lauterbourg 183
Council Bluffs 123
Ho Chi Minh City 113
Hong Kong 102
New York 95
Hanoi 89
Beijing 86
Helsinki 72
Bordighera 63
Santa Clara 63
Frankfurt am Main 47
Amsterdam 42
Tokyo 30
Los Angeles 24
Dallas 23
Milan 22
Da Nang 19
Buffalo 18
Mexico City 17
Naples 17
Rome 17
Haiphong 16
Phoenix 15
Tianjin 15
Zurich 15
Boardman 13
Chicago 13
Houston 12
Biên Hòa 11
Bologna 11
Baghdad 10
Dublin 10
Atlanta 9
Guatemala City 9
Shanghai 9
Can Tho 8
City of London 8
Lappeenranta 8
Miami 8
Orem 8
Santiago de Compostela 8
Guangzhou 7
Jakarta 7
Seattle 7
Toronto 7
Washington 7
Berlin 6
Certaldo 6
Charlotte 6
Hải Dương 6
Montreal 6
Nairobi 6
Philadelphia 6
Tashkent 6
The Bronx 6
Baltimore 5
Brescia 5
Brooklyn 5
Columbus 5
Kingston 5
Las Vegas 5
Nuremberg 5
San Francisco 5
São Paulo 5
Tampa 5
Turin 5
Belo Horizonte 4
Bắc Giang 4
Bắc Ninh 4
Cagliari 4
Cao Lanh 4
Cardiff 4
Cincinnati 4
Ciudad del Este 4
Curitiba 4
Denver 4
Des Moines 4
Indpls 4
Jacksonville 4
Jeddah 4
Louisville 4
Madrid 4
Malang 4
Minneapolis 4
Munich 4
Ninh Bình 4
Orlando 4
Paris 4
Port of Spain 4
Richmond 4
Rio de Janeiro 4
San José 4
Shenzhen 4
Totale 24.820
Nome #
Clinical characteristics, management and in-hospital mortality of patients with COVID-19 In Genoa, Italy 342
RAPP-children: A new tool for assessing quality of life in patients with asthma and rhinitis 271
Administration of a polyvalent mechanical bacterial lysate to elderly patients with COPD: Effects on circulating T, B and NK cells. 209
Allergic Rhinitis and its Impact on Asthma (ARIA) Classes in MASK-air Users 209
The perception of Obstructive Sleep Apnoea/Hypopnoea Syndrome (OSAHS) among Italian general practitioners 208
Exploring the Relationship between Disease Awareness and Outcomes in Patients with Chronic Obstructive Pulmonary Disease 205
'Emergency exit' of bone-marrow-resident CD34+ DNAM-1 bright CXCR4+-committed lymphoid precursors during chronic infection and inflammation 204
Patients beliefs on intravenous and subcutaneous routes of administration of biologics for severe asthma treatment: A cross-sectional observational survey study 204
Genuair® Usability Test: Results of a National Public Survey of the Elderly 202
null 200
Differentiation of COVID-19 signs and symptoms from allergic rhinitis and common cold: An ARIA-EAACI-GA2LEN consensus 196
The bacterial lysate Lantigen B reduces the number of acute episodes in patients with recurrent infections of the respiratory tract: the results of a double blind, placebo controlled, multicenter clinical trial 195
A new tool to assess and monitor the burden of chronic cough on quality of life: Chronic Cough Impact Questionnaire. 194
Prevalence and prognostic value of cardiac troponin in elderly patients hospitalized for COVID-19 190
"Trying, But Failing" - The Role of Inhaler Technique and Mode of Delivery in Respiratory Medication Adherence 185
The administration of a polyvalent mechanical bacterial lysate in elderly patients with COPD results in serological signs of an efficient immune response associated with a reduced number of acute episodes 183
Antiallergic drugs and quality of life. 182
Sleep complaints and sleep breathing disorders in upper and lower obstructive lung diseases 179
A new tool to evaluate the impact of chronic urticaria on quality of life: chronic urticaria quality of life questionnaire (CU-QoL). 178
Chronic Urticaria Patient Perspective (CUPP): The First Validated Tool for Assessing Quality of Life in Clinical Practice 178
An update on allergen immunotherapy and asthma 177
COPD treatment: Real life and experimental effects on peripheral NK cells, their receptors expression and their IFN-γ secretion. 175
Basi Patogenetiche ed anatomopatologiche della flogosi allergica nell’asma bronchiale 174
Allergic diseases and their impact on quality of life. 174
Clara cell 16 protein in COPD sputum: A marker of small airways damage? 172
Why use long acting bronchodilators in chronic obstructive lung diseases? An extensive review on formoterol and salmeterol 172
CD4+CD25highCD127- regulatory T-cells in COPD: Smoke and drugs effect 172
Clinical and Functional Characteristics of COPD Patients Across GOLD Classifications: Results of a Multicenter Observational Study 170
Clinical characteristics, management and in-hospital mortality of patients with coronavirus disease 2019 in Genoa, Italy 170
Allergic rhinitis and asthma ad hoc survey: clinical and psychological perspectives. 169
The unmet need for pertussis prevention in patients with chronic obstructive pulmonary disease in the Italian context 168
The Portuguese version of Rhinitis and Asthma Patient's Perspective (RAPP): Validation and assessment 168
The relationship between allergen immunotherapy and omalizumab for treating asthma 166
Sub-lingual administration of a polyvalent mechanical bacterial lysate (PMBL) in patients with moderate, severe, or very severe chronic obstructive pulmonary disease (COPD) according to the GOLD spirometric classification: A multicentre, double-blind, randomised, controlled, phase IV study (AIACE study: Advanced Immunological Approach in COPD Exacerbation) 165
RhinAsthma patient perspective: A Rasch validation study 165
Viruses and bacteria in acute asthma exacerbations--a GA² LEN-DARE systematic review. 164
Umeclidinium for the treatment of uncontrolled asthma 164
Patient-physician relationship in the management of asthma: Multicentric approach in Latin America 164
Adherence to treatment: assessment of an unmet need in asthma. 163
Pidotimod: The state of art 163
Biosimilars in allergic diseases 163
Which factors affect the choice of the inhaler in chronic obstructive respiratory diseases? 162
Recommendations for assessing patient-reported outcomes and health-related quality of life in patients with urticaria: a GA(2) LEN taskforce position paper. 162
Manifesto on small airway involvement and management in asthma and chronic obstructive pulmonary disease: an Interasma (Global Asthma Association - GAA) and World Allergy Organization (WAO) document endorsed by Allergic Rhinitis and its Impact on Asthma (ARIA) and Global Allergy and Asthma European Network (GA2LEN) 161
Determinants and impact of suboptimal asthma control in Europe: The INTERNATIONAL CROSS-SECTIONAL AND LONGITUDINAL ASSESSMENT ON ASTHMA CONTROL (LIAISON) study 161
Cost-description and multiple imputation of missing values: the SATisfaction and adherence to COPD treatment (SAT) study 161
The ARGA study with general practitioners: Impact of medical education on asthma/rhinitis management 160
Diurnal mouthpiece ventilation and nocturnal non-invasive ventilation versus tracheostomy invasive ventilation in patients with amyotrophic lateral sclerosis. 160
Adherence to asthma treatments: 'We know, we intend, we advocate' 158
Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needs. 157
Disease awareness in patients with COPD: measurement and extent 157
Minimal clinical important difference (MCID) of the Thai chronic urticaria quality of life questionnaire (CU-Q2oL) 155
Minimal important difference of the Chronic Urticaria Quality of Life Questionnaire (CU-Q2oL) 155
InternationaL cross-sectIonAl and longItudinal assessment on aSthma cONtrol in European adult patients--the LIAISON study protocol. 154
Randomized controlled trials and real life studies. Approaches and methodologies: A clinical point of view 154
Disability in moderate chronic obstructive pulmonary disease: Prevalence, burden and assessment-results from a real-life study 153
Asthma management in a specialist setting: Results of an Italian Respiratory Society survey 152
MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): The new generation guideline implementation 152
Illness perception, mood and coping strategies in allergic rhinitis: are there differences among ARIA classes of severity? 151
Impact of asthma and comorbid allergic rhinitis on quality of life and control in patients of italian general practitioners 150
Coping with asthma: is the physician able to identify patient's behaviour? 149
ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle 149
A Framework For Step Down Or Therapeutic Re-Organization For Withdrawal Of Inhaled Corticosteroids In Selected Patients With COPD: A Proposal For COPD Management 149
Why do doctors and patients not follow guidelines? 147
Long-acting bronchodilators improve health related quality of life in patients with COPD. 147
Rhinasthma: a new specific QoL questionnaire for patients with rhinitis and asthma. 146
New therapies for allergic rhinitis 146
RHINASTHMA-Adolescents: a new quality of life tool for patients with respiratory allergy 146
Non-invasive ventilation in acute respiratory failure of patients with obesity hypoventilation syndrome 146
New treatment options in allergic rhinitis: patient considerations and the role of ciclesonide. 146
Extensive activation, tissue trafficking, turnover and functional impairment of NK cells in COVID-19 patients at disease onset associates with subsequent disease severity 146
Recommendations for assessing patient-reported outcomes and health-related quality of life in clinical trials on allergy: a GA(2)LEN taskforce position paper. 145
Quality-of-life issues in survivors to anaphylactic reactions to drugs 145
Patient-reported outcomes in asthma clinical trials 145
Pitfalls in respiratory allergy management: alexithymia and its impact on patient-reported outcomes. 144
Effects of mometasone furoate on the quality of life: a randomized placebo-controlled trial in persistent allergic rhinitis and intermittent asthma using the Rhinasthma questionnaire. 142
Does a low-density gas mixture or oxygen supplementation improve exercise training in COPD? 142
Does asthma control correlate with quality of life related to upper and lower airways? A real life study. 141
Asthma management failure: a flaw in physicians' behavior or in patients' knowledge? 141
The impact of GINA suggested drugs for the treatment of asthma on Health-Related Quality of Life: a GA(2)LEN review. 141
Dupilumab Effectiveness in Patients with Severe Allergic Asthma Non-Responsive to Omalizumab 140
Asthma treatment: 'magic bullets which seek their own targets'. 140
MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis 140
Quality of life and patients' satisfaction in chronic urticaria and respiratory allergy. 139
Phenotypes/endotypes-driven treatment in asthma 139
Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma 139
Aqua©: Allergy questionnaire for athletes. Development and validation 138
From "blockbusters" to "biosimilars": An opportunity for patients, medical specialists and health care providers 138
Continuing Medical Education:an international reality 138
Transoral glossoepiglottopexy in the treatment of adult obstructive sleep apnoea: A surgical approach [Glossoepiglottoplastica con approccio trans-orale nel trattamento delle apnee ostruttive notturne nell’adulto] 138
“ Immunologia dell’apparato Respiratorio e metodiche di studio “ Cap 8 137
Asthma and COPD: Interchangeable use of inhalers. A document of Italian Society of Allergy, Asthma and Clinical Immmunology (SIAAIC) & Italian Society of Respiratory Medicine (SIMeR) 137
Systematic review on the efficacy of fexofenadine in seasonal allergic rhinitis: a meta-analysis of randomized, double-blind, placebo-controlled clinical trials. 135
Quality of life in Duchenne muscular dystrophy: the subjective impact on children and parents. 135
Sleep disturbances in allergic diseases. 134
Choosing wisely: Practical considerations on treatment efficacy and safety of asthma in the elderly 134
Worldwide differences on the concept of control of asthma. 133
ARIA-suggested drugs for allergic rhinitis: what impact on quality of life? A GA2LEN review. 133
Rhinitis: Adherence to treatment and new technologies 133
Asthma management among different specialists: results from a national Italian survey 133
Totale 16.263
Categoria #
all - tutte 92.713
article - articoli 91.862
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 851
Totale 185.426


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.437 127 164 117 243 52 250 119 570 182 213 106 294
2022/20232.276 249 118 21 236 326 413 52 181 395 55 184 46
2023/20241.097 61 161 24 115 98 167 90 79 57 28 96 121
2024/20253.448 45 264 131 223 486 375 328 486 184 213 343 370
2025/20267.198 735 195 838 441 828 695 1.128 321 512 632 417 456
2026/2027439 439 0 0 0 0 0 0 0 0 0 0 0
Totale 28.196